Drug Delivery

Topical combo based on Pfizer and Novartis drugs advances after clearing early clinical test

By Nick Paul Taylor

Pfizer’s JAK inhibitor Xeljanz and Novartis’ S1P modulator Gilenya both have their share of safety problems. But Vyne Therapeutics thinks it can tame the molecules by combining them in a topical product—and is pushing ahead after getting an early look at clinical data on the candidate. 

read more

Novaliq eyes dermatology opportunity, spinning off 3 programs and securing $15M for clinical trials

By Nick Paul Taylor

Novaliq is spinning off its dermatology candidates. Working with VCs, the biotech has set up Dermaliq Therapeutics and secured $15 million to fund early-phase clinical trials of dermatology candidates based on cutaneous drug delivery technology.

read more

Pfizer takes a surprising hit to its rare disease plan as FDA snubs new growth deficiency med

By Angus Liu

Pfizer’s bid to buttress its presence in a pediatric rare disease has hit a snag, giving competitor Acendis Pharma a longer runway to gather speed with a newly approved treatment.

read more

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Sponsored by: Thermo Fisher Scientific

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: QC for ex vivo manipulated cell lines and tissues

Sponsored by: Thermo Fisher Scientific

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Sponsored by: IQVIA

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Sponsored by: Catalent Biologics

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Sponsored by: Catalent Biologics

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Sponsored by: Thermo Fisher Scientific

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Sponsored by: Box

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.